Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding

  1. Paul Chappell
  2. El Kahina Meziane
  3. Michael Harrison
  4. Łukasz Magiera
  5. Clemens Hermann
  6. Laura Mears
  7. Antony G Wrobel
  8. Charlotte Durant
  9. Lise Lotte Nielsen
  10. Soren Buus
  11. Nicola Ternette
  12. William Mwangi
  13. Colin Butter
  14. Venugopal Nair
  15. Trudy Ahyee
  16. Richard Duggleby
  17. Alejandro Madrigal
  18. Pietro Roversi
  19. Susan M Lea
  20. Jim Kaufman  Is a corresponding author
  1. University of Oxford, United Kingdom
  2. University of Cambridge, United Kingdom
  3. University of Copenhagen, Denmark
  4. Pirbright Institute, United Kingdom
  5. The Royal Free Hospital, United Kingdom

Abstract

Highly polymorphic MHC molecules are at the heart of adaptive immune responses, playing crucial roles in many kinds of disease and in vaccination. We report that breadth of peptide presentation and level of cell surface expression of class I molecules are inversely correlated in both chickens and humans. This relationship correlates with protective responses against infectious pathogens including Marek's disease virus leading to lethal tumours in chickens and HIV infection progressing to AIDS in humans. We propose that differences in peptide binding repertoire define two groups of MHC class I molecules strategically evolved as generalists and specialists for different modes of pathogen resistance. We suggest that differences in cell surface expression level ensure the development of optimal peripheral T cell responses. The inverse relationship of peptide repertoire and expression is evidently a fundamental property of MHC molecules, with ramifications extending beyond immunology and medicine to evolutionary biology and conservation.

Article and author information

Author details

  1. Paul Chappell

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. El Kahina Meziane

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Michael Harrison

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Łukasz Magiera

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Clemens Hermann

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Laura Mears

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Antony G Wrobel

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Charlotte Durant

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Lise Lotte Nielsen

    Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  10. Soren Buus

    Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  11. Nicola Ternette

    Target Discovery Institute, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. William Mwangi

    Pirbright Institute, Compton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Colin Butter

    Pirbright Institute, Compton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Venugopal Nair

    Pirbright Institute, Compton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Trudy Ahyee

    Anthony Nolan Research Institute, The Royal Free Hospital, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. Richard Duggleby

    Anthony Nolan Research Institute, The Royal Free Hospital, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  17. Alejandro Madrigal

    Anthony Nolan Research Institute, The Royal Free Hospital, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  18. Pietro Roversi

    Department of Biochemistry, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  19. Susan M Lea

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  20. Jim Kaufman

    Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    jfk31@cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Arup K Chakraborty, Massachusetts Institute of Technology, United States

Ethics

Animal experimentation: All procedures involving chickens were carried out at the University of Cambridge under Home Office project license PPL 80/2420 and with ethical approval of the Local Ethical Review Committee.

Human subjects: Anthony Nolan registrants signed written consent forms, with all procedures carried out under Human Tissue Act licensing number 22513 and with approval of the local Research Ethics committee (REC).

Version history

  1. Received: October 26, 2014
  2. Accepted: April 10, 2015
  3. Accepted Manuscript published: April 10, 2015 (version 1)
  4. Version of Record published: May 6, 2015 (version 2)

Copyright

© 2015, Chappell et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,418
    views
  • 931
    downloads
  • 102
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paul Chappell
  2. El Kahina Meziane
  3. Michael Harrison
  4. Łukasz Magiera
  5. Clemens Hermann
  6. Laura Mears
  7. Antony G Wrobel
  8. Charlotte Durant
  9. Lise Lotte Nielsen
  10. Soren Buus
  11. Nicola Ternette
  12. William Mwangi
  13. Colin Butter
  14. Venugopal Nair
  15. Trudy Ahyee
  16. Richard Duggleby
  17. Alejandro Madrigal
  18. Pietro Roversi
  19. Susan M Lea
  20. Jim Kaufman
(2015)
Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding
eLife 4:e05345.
https://doi.org/10.7554/eLife.05345

Share this article

https://doi.org/10.7554/eLife.05345

Further reading

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.